BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 184022)

  • 1. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
    Kropp R
    Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
    Roldaan AC; de Jong C
    Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].
    Kawai M; Maekawa N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
    Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
    Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
    Müller M; Fehm HL; Homoki J; Teller WM
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].
    Rott Z; Fajt E; Tóth S; Hammer I; Nagy G
    Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stimulation of the adrenal cortex in long-term steroid therapy. Increase of free cortisol in the urine following depot ACTH administration].
    Nolte D; Gallenberger S; Borgolte H; Vecsei P; Haack D
    Fortschr Med; 1986 Jun; 104(22):444-7. PubMed ID: 3017824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthetic ACTH in theumatic diseases: (author's transl)].
    Hieber F
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal ACTH-depot therapy].
    Klimek M; Kołodziejski L; Gołabek D; Tomaszewska B; Bałajewicz M
    Przegl Lek; 2006; 63(2):88-90. PubMed ID: 16967715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bronchial asthma. Pathogenetic assumptions - therapeutic guidelines - the significance of synthetic corticotrophin (ACTH) in its treatment (author's transl)].
    Brinkmann OH; Junge-Hülsing G
    Med Klin; 1975 Nov; 70(45):1821-6. PubMed ID: 172768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
    Usobiaga JL
    Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTH therapy of dermatoses].
    Schuppli R
    Hautarzt; 1977 Jan; 28(1):1-4. PubMed ID: 190189
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye].
    Fricke HJ; Heydenreich A; Thiel U; Schröder D
    Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
    Harnack K; Flegel P
    Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic depot-ACTH, plasmacortisol levels, and asthmatic syndrome (author's transl)].
    Illig H; Giesen HK
    Med Klin; 1975 Feb; 70(9):377-9. PubMed ID: 164616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.
    Brombacher PJ; Maesen FP; Gijzen AH
    Lancet; 1975 Feb; 1(7904):456. PubMed ID: 48646
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of salbutamol aerosol in chronic obstructive airways disease.
    Zwi S; Kanarek DJ; McMurdo J; Goldman HI
    Postgrad Med J; 1971 Mar; 47():Suppl:112-5. PubMed ID: 5576147
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.